@uchicagoobgyn.bsky.social
New publication: Dr. Jessica Long co-authored a chapter on ovarian tissue cryopreservation and transposition in the newly released Pediatric and Adolescent Gynecologic Surgery: Management, Surgical Approaches and Post-Operative Care.
Learn more: loom.ly/93h5rKg
Learn more: loom.ly/93h5rKg
November 25, 2025 at 9:46 PM
New publication: Dr. Jessica Long co-authored a chapter on ovarian tissue cryopreservation and transposition in the newly released Pediatric and Adolescent Gynecologic Surgery: Management, Surgical Approaches and Post-Operative Care.
Learn more: loom.ly/93h5rKg
Learn more: loom.ly/93h5rKg
A new study led by Dr. Sandra Laveaux in the International Journal of Women's Health highlights what patients and providers prioritize when choosing medications for uterine fibroids.
Findings support more personalized, patient-centered care through shared decision-making.
Read: loom.ly/UjfKib0
Findings support more personalized, patient-centered care through shared decision-making.
Read: loom.ly/UjfKib0
November 6, 2025 at 7:24 PM
A new study led by Dr. Sandra Laveaux in the International Journal of Women's Health highlights what patients and providers prioritize when choosing medications for uterine fibroids.
Findings support more personalized, patient-centered care through shared decision-making.
Read: loom.ly/UjfKib0
Findings support more personalized, patient-centered care through shared decision-making.
Read: loom.ly/UjfKib0
New in F&S Science: UChicago OB/GYN researchers developed and validated a protocol for transvaginal shear wave elastography to measure uterine and leiomyoma stiffness.
Read more: pubmed.ncbi.nlm.nih.gov/40934972/
Read more: pubmed.ncbi.nlm.nih.gov/40934972/
October 30, 2025 at 2:40 PM
New in F&S Science: UChicago OB/GYN researchers developed and validated a protocol for transvaginal shear wave elastography to measure uterine and leiomyoma stiffness.
Read more: pubmed.ncbi.nlm.nih.gov/40934972/
Read more: pubmed.ncbi.nlm.nih.gov/40934972/
New RCT led by Dr. Kimberly Kenton, with co-author Dr. Sarah Collins, published in the American Journal of Gynecology, shows similar satisfaction at 2 vs. 6 weeks for resuming vaginal intercourse after retropubic sling. No mesh exposures and no difference in outcomes.
Read: loom.ly/Tpg8wOU
Read: loom.ly/Tpg8wOU
October 23, 2025 at 6:22 PM
New RCT led by Dr. Kimberly Kenton, with co-author Dr. Sarah Collins, published in the American Journal of Gynecology, shows similar satisfaction at 2 vs. 6 weeks for resuming vaginal intercourse after retropubic sling. No mesh exposures and no difference in outcomes.
Read: loom.ly/Tpg8wOU
Read: loom.ly/Tpg8wOU
Over 50 years, OB/GYN residents & faculty have undergone a near-complete reversal in gender composition. New study by Drs. Romero & Kenton projects that by 2035, <1% of OB/GYN residents may be male.
Learn more: bit.ly/4666dkU
Learn more: bit.ly/4666dkU
October 22, 2025 at 7:37 PM
Over 50 years, OB/GYN residents & faculty have undergone a near-complete reversal in gender composition. New study by Drs. Romero & Kenton projects that by 2035, <1% of OB/GYN residents may be male.
Learn more: bit.ly/4666dkU
Learn more: bit.ly/4666dkU
Dr. Kimberly Kenton coauthored ACOG’s new national curriculum for URPS: PROLOG: Urogynecology, 2nd Ed!
Also featuring Dr. Sarah Ashmore (former Urogynecology Fellow) & Dr. Juraj Letko (Urogynecologist).
Learn more: bit.ly/3HLQ788
#ObGyn #Urogynecology #UChicagoMedicine
Also featuring Dr. Sarah Ashmore (former Urogynecology Fellow) & Dr. Juraj Letko (Urogynecologist).
Learn more: bit.ly/3HLQ788
#ObGyn #Urogynecology #UChicagoMedicine
October 17, 2025 at 7:22 PM
Dr. Kimberly Kenton coauthored ACOG’s new national curriculum for URPS: PROLOG: Urogynecology, 2nd Ed!
Also featuring Dr. Sarah Ashmore (former Urogynecology Fellow) & Dr. Juraj Letko (Urogynecologist).
Learn more: bit.ly/3HLQ788
#ObGyn #Urogynecology #UChicagoMedicine
Also featuring Dr. Sarah Ashmore (former Urogynecology Fellow) & Dr. Juraj Letko (Urogynecologist).
Learn more: bit.ly/3HLQ788
#ObGyn #Urogynecology #UChicagoMedicine
We’re proud to recognize resident Drs. Neha Reddy and Samantha Neal (PGY3s) for their leadership in UCM’s GME Champion programs. Their work in community engagement and resident well-being exemplifies the mission of our department.
#MedEd #OBGYN #ResidentLeadership
#MedEd #OBGYN #ResidentLeadership
October 15, 2025 at 7:11 PM
We’re proud to recognize resident Drs. Neha Reddy and Samantha Neal (PGY3s) for their leadership in UCM’s GME Champion programs. Their work in community engagement and resident well-being exemplifies the mission of our department.
#MedEd #OBGYN #ResidentLeadership
#MedEd #OBGYN #ResidentLeadership
2 new studies from Dr. Sarah Ackroyd & team:
1️⃣ In stage I–III endometrial cancer, no differences in survival by race or neighborhood disadvantage: loom.ly/v2cCbUk
2️⃣ In grade 3 tumors, no racial differences in HER2 or molecular subtype: loom.ly/sC7ZWMo
1️⃣ In stage I–III endometrial cancer, no differences in survival by race or neighborhood disadvantage: loom.ly/v2cCbUk
2️⃣ In grade 3 tumors, no racial differences in HER2 or molecular subtype: loom.ly/sC7ZWMo
October 9, 2025 at 4:41 PM
2 new studies from Dr. Sarah Ackroyd & team:
1️⃣ In stage I–III endometrial cancer, no differences in survival by race or neighborhood disadvantage: loom.ly/v2cCbUk
2️⃣ In grade 3 tumors, no racial differences in HER2 or molecular subtype: loom.ly/sC7ZWMo
1️⃣ In stage I–III endometrial cancer, no differences in survival by race or neighborhood disadvantage: loom.ly/v2cCbUk
2️⃣ In grade 3 tumors, no racial differences in HER2 or molecular subtype: loom.ly/sC7ZWMo
Planning a pregnancy or pregnant with IBD? UChicago Medicine now offers a dedicated clinic where MFM + GI specialists work together to support you every step of the way. Held monthly at DCAM.
Talk to your provider about a referral. #IBD #PregnancyCare
Talk to your provider about a referral. #IBD #PregnancyCare
October 1, 2025 at 4:47 PM
Planning a pregnancy or pregnant with IBD? UChicago Medicine now offers a dedicated clinic where MFM + GI specialists work together to support you every step of the way. Held monthly at DCAM.
Talk to your provider about a referral. #IBD #PregnancyCare
Talk to your provider about a referral. #IBD #PregnancyCare
New in Pediatric Annals: Drs. Jessica Long & Carrie Smith guest edited a special edition on Pediatric & Adolescent Gynecology. Their lead article, “Deciding Together,” explores the complexities of care for adolescents.
Read here: http://bit.ly/48BJSyD
#OBGYN #AdolescentHealth
Read here: http://bit.ly/48BJSyD
#OBGYN #AdolescentHealth
September 30, 2025 at 7:55 PM
New in Pediatric Annals: Drs. Jessica Long & Carrie Smith guest edited a special edition on Pediatric & Adolescent Gynecology. Their lead article, “Deciding Together,” explores the complexities of care for adolescents.
Read here: http://bit.ly/48BJSyD
#OBGYN #AdolescentHealth
Read here: http://bit.ly/48BJSyD
#OBGYN #AdolescentHealth
New in Urogynecology: Dr. Maggie Mueller led an international AUGS panel to develop the first evidence-based consensus on postoperative activity after urogynecologic surgery.
Key takeaway: Liberal activity is safe.
Learn more: http://bit.ly/46F4xPN
#Urogynecology #AUGS #WomensHealth
Key takeaway: Liberal activity is safe.
Learn more: http://bit.ly/46F4xPN
#Urogynecology #AUGS #WomensHealth
September 29, 2025 at 7:19 PM
New in Urogynecology: Dr. Maggie Mueller led an international AUGS panel to develop the first evidence-based consensus on postoperative activity after urogynecologic surgery.
Key takeaway: Liberal activity is safe.
Learn more: http://bit.ly/46F4xPN
#Urogynecology #AUGS #WomensHealth
Key takeaway: Liberal activity is safe.
Learn more: http://bit.ly/46F4xPN
#Urogynecology #AUGS #WomensHealth
Reposted
A new study published in @gynoncjnls shows that delivering care at high-resource tertiary centers may eliminate racial and socioeconomic disparities in women with treatable stage I-III endometrioid endometrial cancer. @uchicagoobgyn.bsky.social
ow.ly/hWtP50WUb7F
ow.ly/hWtP50WUb7F
Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center - PubMed
In women with Stage I-III EEC treated at a single tertiary referral center, we did not find differences in outcomes when analyzed by ADI or race. Given previously reported racial disparities in outcom...
ow.ly
September 9, 2025 at 8:12 PM
A new study published in @gynoncjnls shows that delivering care at high-resource tertiary centers may eliminate racial and socioeconomic disparities in women with treatable stage I-III endometrioid endometrial cancer. @uchicagoobgyn.bsky.social
ow.ly/hWtP50WUb7F
ow.ly/hWtP50WUb7F
New in @acadmedjournal.bsky.social: Dr. Sarah Wagner and colleagues share outcomes from a national “Readiness for Residency” curriculum supporting OB/GYN interns in building resilience, community and professional identity. Now adopted by CREOG programs nationwide.
Read: bit.ly/3HJ1mOy
@acog.org
Read: bit.ly/3HJ1mOy
@acog.org
August 25, 2025 at 9:21 PM
New in @acadmedjournal.bsky.social: Dr. Sarah Wagner and colleagues share outcomes from a national “Readiness for Residency” curriculum supporting OB/GYN interns in building resilience, community and professional identity. Now adopted by CREOG programs nationwide.
Read: bit.ly/3HJ1mOy
@acog.org
Read: bit.ly/3HJ1mOy
@acog.org
Our recent publication by @lisaschweizer.bsky.social, @mpibiochem.bsky.social & @lengyel-ovca-lab.bsky.social is featured on the cover of @cp-cancercell.bsky.social! The artwork illustrates the malignant progression of borderline ovarian tumors to LGSOCs.
Read: www.cell.com/cancer-cell/...
Read: www.cell.com/cancer-cell/...
August 12, 2025 at 1:41 PM
Our recent publication by @lisaschweizer.bsky.social, @mpibiochem.bsky.social & @lengyel-ovca-lab.bsky.social is featured on the cover of @cp-cancercell.bsky.social! The artwork illustrates the malignant progression of borderline ovarian tumors to LGSOCs.
Read: www.cell.com/cancer-cell/...
Read: www.cell.com/cancer-cell/...
Reposted
Leap onto the August issue of Cancer Cell, out now: www.cell.com/cancer-cell/...
August 11, 2025 at 3:47 PM
Leap onto the August issue of Cancer Cell, out now: www.cell.com/cancer-cell/...
New in Urogynecology: Dr. Juraj Letko and colleagues highlight uterine preservation as a safe, effective option in prolapse surgery, supporting patient-centered, evidence-based care.
Read: pubmed.ncbi.nlm.nih.gov/40168462/
Read: pubmed.ncbi.nlm.nih.gov/40168462/
July 25, 2025 at 7:57 PM
New in Urogynecology: Dr. Juraj Letko and colleagues highlight uterine preservation as a safe, effective option in prolapse surgery, supporting patient-centered, evidence-based care.
Read: pubmed.ncbi.nlm.nih.gov/40168462/
Read: pubmed.ncbi.nlm.nih.gov/40168462/
New from UChicago OB/GYN: Drs. Perinchery (PGY3) and Mills review sentinel lymph node mapping in vulvar and cervical cancers in Gynecologic Oncology Reports, highlighting clinical evidence, surgical techniques and institutional insights.
Read: www.sciencedirect.com/science/arti...
#gynonc
Read: www.sciencedirect.com/science/arti...
#gynonc
July 24, 2025 at 9:25 PM
New from UChicago OB/GYN: Drs. Perinchery (PGY3) and Mills review sentinel lymph node mapping in vulvar and cervical cancers in Gynecologic Oncology Reports, highlighting clinical evidence, surgical techniques and institutional insights.
Read: www.sciencedirect.com/science/arti...
#gynonc
Read: www.sciencedirect.com/science/arti...
#gynonc
New in @nature.com: Drs. @lengyel-ovca-lab.bsky.social, Janna Heide & co-authors discovered a first-of-its-kind NNMT inhibitor that reprograms cancer-associated fibroblasts and restores immune response in ovarian cancer. A major step toward more effective therapies.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity - Nature
An NNMT inhibitor reduces tumour burden and metastasis in multiple mouse cancer models and restores immune checkpoint blockade efficacy by decreasing cancer-associated-fibroblast-mediated recruitment ...
www.nature.com
July 23, 2025 at 8:00 PM
New in @nature.com: Drs. @lengyel-ovca-lab.bsky.social, Janna Heide & co-authors discovered a first-of-its-kind NNMT inhibitor that reprograms cancer-associated fibroblasts and restores immune response in ovarian cancer. A major step toward more effective therapies.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted
🔥 Hot off the press: In a new @nature.com study, Ernst Lengyel, MD, PhD and team show that blocking NNMT in tumor-supporting cells restores immune response & stops ovarian cancer growth, offering a new strategy to treat one of the deadliest cancers. @lengyel-ovca-lab.bsky.social
ow.ly/zzfZ50Wu3UW
ow.ly/zzfZ50Wu3UW
July 23, 2025 at 3:26 PM
🔥 Hot off the press: In a new @nature.com study, Ernst Lengyel, MD, PhD and team show that blocking NNMT in tumor-supporting cells restores immune response & stops ovarian cancer growth, offering a new strategy to treat one of the deadliest cancers. @lengyel-ovca-lab.bsky.social
ow.ly/zzfZ50Wu3UW
ow.ly/zzfZ50Wu3UW
Dr. Kimberly Kenton, Section Chief of Urogynecology & Reconstructive Pelvic Surgery, delivered two invited presentations at #IUGAEUGA2025 in Barcelona: a plenary session on cancer & pelvic floor health, & a masterclass in robotic urogynecology.
#PelvicHealth #RoboticSurgery #WomensHealth
#PelvicHealth #RoboticSurgery #WomensHealth
July 3, 2025 at 4:56 PM
Dr. Kimberly Kenton, Section Chief of Urogynecology & Reconstructive Pelvic Surgery, delivered two invited presentations at #IUGAEUGA2025 in Barcelona: a plenary session on cancer & pelvic floor health, & a masterclass in robotic urogynecology.
#PelvicHealth #RoboticSurgery #WomensHealth
#PelvicHealth #RoboticSurgery #WomensHealth
Reposted
Online Now: Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression
Schweizer et al. profile the tumor progression from non-invasive serous borderline tumors of the ovary to metastatic low-grade serous ovarian cancer. By integrating cell-type resolved Deep Visual Proteomics and spatial transcriptomics, they identify and validate several drivers of transformation as well as a novel combination treatment for this chemo-resistant disease.
dlvr.it
June 27, 2025 at 2:17 PM
Online Now: Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression
Join us in celebrating the UChicago OB/GYN Resident Class of 2025!
Drs. Brockman, Byl, Hood, Hripko, Kar, Lamacki & Smith, thank you for your dedication to patient care, scholarship & leadership. We wish you all the best in the next chapter.
#ResidencyGraduation
Drs. Brockman, Byl, Hood, Hripko, Kar, Lamacki & Smith, thank you for your dedication to patient care, scholarship & leadership. We wish you all the best in the next chapter.
#ResidencyGraduation
June 26, 2025 at 9:10 PM
Join us in celebrating the UChicago OB/GYN Resident Class of 2025!
Drs. Brockman, Byl, Hood, Hripko, Kar, Lamacki & Smith, thank you for your dedication to patient care, scholarship & leadership. We wish you all the best in the next chapter.
#ResidencyGraduation
Drs. Brockman, Byl, Hood, Hripko, Kar, Lamacki & Smith, thank you for your dedication to patient care, scholarship & leadership. We wish you all the best in the next chapter.
#ResidencyGraduation
Reposted
An interdisciplinary study uncovers how benign borderline ovarian tumors develop into invasive low-grade serous carcinoma, opening a new avenue for targeted therapy.
❕Publication: www.cell.com/cancer-cell/...
❕Press Release: www.biochem.mpg.de/when-tumors-...
❕Publication: www.cell.com/cancer-cell/...
❕Press Release: www.biochem.mpg.de/when-tumors-...
June 26, 2025 at 5:27 PM
An interdisciplinary study uncovers how benign borderline ovarian tumors develop into invasive low-grade serous carcinoma, opening a new avenue for targeted therapy.
❕Publication: www.cell.com/cancer-cell/...
❕Press Release: www.biochem.mpg.de/when-tumors-...
❕Publication: www.cell.com/cancer-cell/...
❕Press Release: www.biochem.mpg.de/when-tumors-...
A new publication in #CancerCell uncovers how borderline ovarian tumors evolve into low-grade serous ovarian cancer & identifies a promising new treatment strategy.
www.sciencedirect.com/science/arti...
@lisaschweizer.bsky.social @mannlab.bsky.social @lengyel-ovca-lab.bsky.social
www.sciencedirect.com/science/arti...
@lisaschweizer.bsky.social @mannlab.bsky.social @lengyel-ovca-lab.bsky.social
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression
Epithelial serous borderline tumors (SBT) are non-invasive neoplastic ovarian lesions that may recur as chemo-resistant low-grade serous cancer (LGSC)…
www.sciencedirect.com
June 26, 2025 at 4:30 PM
A new publication in #CancerCell uncovers how borderline ovarian tumors evolve into low-grade serous ovarian cancer & identifies a promising new treatment strategy.
www.sciencedirect.com/science/arti...
@lisaschweizer.bsky.social @mannlab.bsky.social @lengyel-ovca-lab.bsky.social
www.sciencedirect.com/science/arti...
@lisaschweizer.bsky.social @mannlab.bsky.social @lengyel-ovca-lab.bsky.social
Reposted
Our paper on ovarian cancer #LGSC is out in @Cancer_Cell. Using deep visual proteomics #DVP and spatial transcriptomics, we mapped how non-invasive tumors become deadly ovarian disease, and found a promising new treatment combination.
www.cell.com/cancer-cell/...
www.cell.com/cancer-cell/...
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression
Schweizer et al. profile the tumor progression from non-invasive serous borderline
tumors of the ovary to metastatic low-grade serous ovarian cancer. By integrating
cell-type resolved Deep Visual Prot...
www.cell.com
June 26, 2025 at 3:20 PM
Our paper on ovarian cancer #LGSC is out in @Cancer_Cell. Using deep visual proteomics #DVP and spatial transcriptomics, we mapped how non-invasive tumors become deadly ovarian disease, and found a promising new treatment combination.
www.cell.com/cancer-cell/...
www.cell.com/cancer-cell/...